# Accenture plc (ACN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Accenture plc's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ACN/mda/fy2025/): filed 2025-10-10; accession 0001467373-25-000217 (https://www.sec.gov/Archives/edgar/data/1467373/000146737325000217/acn-20250831.htm); latest 10-K
- [FY 2024 MD&A](/company/ACN/mda/fy2024/): filed 2024-10-10; accession 0001467373-24-000278 (https://www.sec.gov/Archives/edgar/data/1467373/000146737324000278/acn-20240831.htm)
- [FY 2023 MD&A](/company/ACN/mda/fy2023/): filed 2023-10-12; accession 0001467373-23-000324 (https://www.sec.gov/Archives/edgar/data/1467373/000146737323000324/acn-20230831.htm)
- [FY 2022 MD&A](/company/ACN/mda/fy2022/): filed 2022-10-12; accession 0001467373-22-000295 (https://www.sec.gov/Archives/edgar/data/1467373/000146737322000295/acn-20220831.htm)
- [FY 2021 MD&A](/company/ACN/mda/fy2021/): filed 2021-10-15; accession 0001467373-21-000229 (https://www.sec.gov/Archives/edgar/data/1467373/000146737321000229/acn-20210831.htm)

Back to /company/ACN/